|
| Case analysis of re-admission of patient with coronavirus disease 2019 after treatment based on greater yin syndrome |
| Hits 1120 Download times 815 Received:May 06, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2020.10.11 |
| Key Words
coronavirus disease 2019;re-admission of patient;greater yin syndrome |
| Author Name | Affiliation | E-mail | | YIN Shengjun | The Department of Traditional Chinese Medicine, The Second Hospital of Tianjin Medical University, Tianjin 300211, China | | | LI Chun | Traditional Chinese Medicine Ancient Books Publishing House, Beijing 100700, China | | | ZHU Lili | School of Life Science, Beijing University of Chinese Medicine, Beijing 102488, China | | | GAO Ao | Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China | | | HUANG Zifeng | Traditional Chinese Medicine Ancient Books Publishing House, Beijing 100700, China | 黄梓峰:Email:huangzifengxl@163.com。 |
|
| Abstract
|
| Recently,the epidemic prevention and control work of coronavirus disease 2019 (COVID-19) in our country has achieved remarkable results. There have been some cases with positivenucleicacidre-examination,with lack of relevanteffectiveness. When COVID-19 patients aftertreatment with gastrointestinal symptoms as the first symptom,the re-admission ones can be analyzedthe pathogenesis and treatment of the disease based on greater yin syndrome in traditional Chinese medicine. Thecritical factorshould be the spleen yang deficiency. The cold-dampness can encumber the channel of foot greater yin when he was attacked by pestilence. So the patients showed recurrent nucleic acid positive. The main treatment should be warmyang and strengthen spleen. We hope that more research will focus on the treatment of recurrent positive and convalescent patients with COVID-19,in order to reduce the psychological pressure of patients,shorten the length of hospitalization treatment,so as to reduce the social and economic impact of the disease. |
|
|
|
|
|
|
|
